Medivolve Inc. (MEDVF)
USD 0.01
(133.33%)
USD 0.01
(133.33%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 575.35 Thousand CAD | -96.0% |
| 2022 | 14.38 Million CAD | -60.66% |
| 2021 | 36.56 Million CAD | 912.45% |
| 2020 | -4.5 Million CAD | -275.73% |
| 2019 | -1.19 Million CAD | -6890.04% |
| 2018 | 17.64 Thousand CAD | 886.93% |
| 2017 | -2242.00 CAD | -999.02% |
| 2016 | -204.00 CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 100.0% |
| 2011 | -2780.00 CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | -100.0% |
| 2007 | 6175.00 CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 262.49 Thousand CAD | 21.11% |
| 2023 Q3 | 136.51 Thousand CAD | -65.22% |
| 2023 FY | 575.35 Thousand CAD | -96.0% |
| 2023 Q4 | 216.73 Thousand CAD | 58.77% |
| 2023 Q1 | 664.14 Thousand CAD | -52.42% |
| 2023 Q2 | 392.5 Thousand CAD | -40.9% |
| 2022 Q4 | 1.39 Million CAD | -42.97% |
| 2022 Q3 | 2.44 Million CAD | -39.31% |
| 2022 Q2 | 4.03 Million CAD | -38.04% |
| 2022 FY | 14.38 Million CAD | -60.66% |
| 2022 Q1 | 6.5 Million CAD | -73.22% |
| 2021 FY | 36.56 Million CAD | 912.45% |
| 2021 Q1 | 1.05 Million CAD | 123.66% |
| 2021 Q2 | 753.53 Thousand CAD | -28.5% |
| 2021 Q3 | 10.45 Million CAD | 1287.88% |
| 2021 Q4 | 24.3 Million CAD | 132.39% |
| 2020 Q4 | -4.45 Million CAD | -4635.64% |
| 2020 FY | -4.5 Million CAD | -275.73% |
| 2020 Q1 | - CAD | 100.0% |
| 2020 Q2 | 209.52 Thousand CAD | 0.0% |
| 2020 Q3 | -94.04 Thousand CAD | -144.89% |
| 2019 Q3 | -150.49 Thousand CAD | -2240.1% |
| 2019 FY | -1.19 Million CAD | -6890.04% |
| 2019 Q1 | 2949.00 CAD | -83.29% |
| 2019 Q2 | 7032.00 CAD | 138.45% |
| 2019 Q4 | -152.1 Thousand CAD | -1.07% |
| 2018 Q4 | 17.64 Thousand CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 FY | 17.64 Thousand CAD | 886.93% |
| 2018 Q1 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | -2242.00 CAD | -999.02% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 FY | -204.00 CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2012 FY | - CAD | 100.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 FY | -2780.00 CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 100.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2008 Q1 | 2017.00 CAD | -67.34% |
| 2008 Q4 | -5479.00 CAD | -340.52% |
| 2008 Q3 | 2278.00 CAD | 92.4% |
| 2008 FY | - CAD | -100.0% |
| 2008 Q2 | 1184.00 CAD | -41.3% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q4 | 6175.00 CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 FY | 6175.00 CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 398.109% |
| Arrayit Corporation | 2.57 Million USD | 77.657% |
| Atlantic International Corp. | -154.23 Thousand USD | 473.037% |
| Biocept, Inc. | -2.58 Million USD | 122.283% |
| Bioqual, Inc. | 7.42 Million USD | 92.255% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -108.46% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.991% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | 67.931% |
| iMD Companies, Inc. | -23.63 Thousand USD | 2534.108% |
| IDenta Corp. | 662.97 Thousand USD | 13.217% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 97.503% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -641.708% |
| InVitro International | 635.98 Thousand USD | 9.534% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 91.233% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | 47.345% |
| NovelStem International Corp. | 12 Thousand USD | -4694.583% |
| Optigenex Inc. | -102.96 Thousand USD | 658.777% |
| PharmChem, Inc. | 3.9 Million USD | 85.264% |
| Proteome Sciences plc | 2.09 Million USD | 72.558% |
| Response Genetics, Inc | 3.94 Million USD | 85.405% |
| Rennova Health, Inc. | 6.26 Million USD | 90.821% |
| RushNet, Inc. | 1.1 Million USD | 47.914% |
| ScreenPro Security Inc. | 856.57 Thousand USD | 32.831% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 242.503% |
| Todos Medical Ltd. | 4.31 Million USD | 86.651% |